Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-012375

Options or other derivatives

  • Director acquired 7,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
GADICKE ANSBERT Director 2021-09-16 Grant or award · Stock Option (Right to Buy) +7,800 7,800 D
Loading xslF345X03/doc4.xml…